Significant Ownership of Jorey Chernett
- Signature - Title
- /s/ Jorey Chernett - Jorey Chernett
- Location
- Bloomfield Hills, MI
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Jorey Chernett.
Follow Filing Activity
Follow Jorey Chernett and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Jorey Chernett
Significant Ownership of Jorey Chernett
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| STIM | Neuronetics, Inc. | Common Stock, $0.01 par value | 14% | $14,381,561 | 9,778,718 | 0% | Chernett Jorey | 06 Apr 2026 | |
| KZIA | KAZIA THERAPEUTICS LTD | American Depositary Shares | 14% | 1,588,129 | +12% | Chernett Jorey | 24 Mar 2026 | ||
| AIRS | Airsculpt Technologies, Inc. | Common Stock, $0.001 Par Value Per Share | 11% | $13,156,713 | +$1,213,955 | 6,781,811 | +10% | Chernett Jorey | 02 Mar 2026 |
| TOI | Oncology Institute, Inc. | Common Stock, $0.0001 Par Value Per Share | 10% | $27,110,730 | 10,115,944 | Chernett Jorey | 13 Mar 2026 | ||
| XGN | EXAGEN INC. | Common Stock, $0.001 Par Value Per Share | 9.9% | $6,469,255 | +$3,169,001 | 2,413,901 | +96% | Chernett Jorey | 31 Mar 2026 |
| AEON | AEON Biopharma, Inc. | Common | 9.9% | $564,250 | 1,128,500 | Chernett Jorey | 27 May 2025 | ||
| Neuronetics, Inc. | Common | 9.9% | 6,827,031 | +55% | Chernett Jorey | 30 Jan 2026 | |||
| OKYO | OKYO Pharma Ltd | Common | 9.5% | $11,824,823 | +$2,541,903 | 3,802,194 | +27% | Chernett Jorey | 31 Dec 2025 |
| FEMY | FEMASYS INC | Common | 9.3% | $2,930,561 | +$1,361,799 | 3,034,335 | +87% | Chernett Jorey | 30 Jun 2025 |
| SMHI | SEACOR Marine Holdings Inc. | Common Stock, $0.01 Par Value Per Share | 6.9% | $14,002,144 | +$3,488,990 | 1,876,963 | +33% | Chernett Jorey | 31 Mar 2026 |
| TRAW | Traws Pharma, Inc. | Common | 6.8% | $668,220 | 543,268 | Chernett Jorey | 14 Jan 2026 | ||
| TLSA | Tiziana Life Sciences Ltd | Common | 5.4% | 6,476,471 | +8.8% | Chernett Jorey | 30 Sep 2025 | ||
| DFPH | Oncology Institute, Inc. | Common | 5.2% | 5,114,944 | Chernett Jorey | 14 Jan 2026 | |||
| ADAG | Adagene Inc. | Ordinary shares, par value US$0.0001 per share | 5.1% | $7,764,445 | 2,389,060 | Chernett Jorey | 16 Mar 2026 | ||
| WW | WW INTERNATIONAL, INC. | Common stock, no par value | 5.1% | $5,783,858 | 507,356 | Chernett Jorey | 14 May 2026 | ||
| LCTX | Lineage Cell Therapeutics, Inc. | Common | 5% | $13,848,454 | 11,445,003 | Chernett Jorey | 22 Sep 2025 | ||
| IOBTQ | IO Biotech, Inc. | Common Stock, $0.001 Par Value Per Share | 0% | $0 | -$45,435 | 0 | -100% | Chernett Jorey | 31 Mar 2026 |
| CALC | CalciMedica, Inc. | Common Stock, $0.0001 Par Value Per Share | 0% | $0 | -$658,211 | 0 | -100% | Chernett Jorey | 31 Mar 2026 |
Schedules 13D/G Reported by Jorey Chernett:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.